Orbimed Advisors - NPS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$105,697,000
+55.4%
2,954,900
+13.0%
1.01%
+42.3%
Q3 2014$68,016,000
+274.0%
2,616,000
+375.5%
0.71%
+231.8%
Q2 2014$18,184,000550,2000.21%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders